Related stocks: Computer Peripheral Equipment, NEC
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
/
Related stocks: Computer Peripheral Equipment, NEC
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Ainos, Inc. (the Company ), incorporated in the State of Texas in 1984, is a dual-platform company advancing artificial intelligence based smelltech technologies and immune therapeutics. Our primary strategic focus is the commercialization of our proprietary scent digitization platform, AI Nose, while we also continue to develop therapeutic assets based on our low-dose oral interferon …
The business is unprofitable at the operating level (-11268.32% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue up 499.0% YoY with margins expanding 55503.9pp.
ROIC dropped from -42.09% to -51.31%, capital efficiency is deteriorating. Negative free cash flow of -$5M. The business is consuming cash, not generating it.
Profitability & Returns
Revenue (TTM)
$18K
▲ +499.0% YoY
Net Income (TTM)
-$14M
▲ +0.6% YoY
Op. Margin
-72393.48%
▲ +55503.9pp YoY
ROIC
-53.99%
▼ -9.2pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$4M
▲ +20.2% YoY
Op. Cash Flow (TTM)
-$4M
▲ +20.5% YoY
Net Debt
$6M
Cash & Equiv.
$3M
5Y CAGR: +49.6%
Continue Research